"JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth" was originally created and published by Medical ...

Shares rose 6.7% to $71.95, putting the stock on pace for its highest close since last September, according to Dow Jones ...

(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for monitoring ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

Dexcom ($DXCM) won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

2020 has been quite a roller coaster ride for the stock markets. The recent positive developments regarding two COVID-19 vaccine candidates has been a drag on the work-from-home stocks but bodes well ...

San Diego, California-based startup Fitabase, which allows researchers to manage and link data from connected consumer devices, has now branched out into glucose monitoring data through a deal with ...

Dexcom is the leader in continuous glucose monitoring systems and the company has created a product that brings parents of children battling type 1 diabetes and users remarkable peace of mind. The San ...